Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NRBO - NeuroBo Pharmaceuticals: Advancing Therapies For Viral Neuropathic And Neurodegenerative Diseases


NRBO - NeuroBo Pharmaceuticals: Advancing Therapies For Viral Neuropathic And Neurodegenerative Diseases

  • NeuroBo Pharmaceuticals is advancing novel disease-modifying therapies for viral, neuropathic and neurodegenerative diseases.
  • The Company has four candidates in the development pipeline, with the lead candidate ANA001 being advanced for treatment of moderate COVID-19.
  • The Company seeks an EUA for the lead candidate, failing which it intends to pursue an NDA via a 505(b)(2) pathway.

For further details see:

NeuroBo Pharmaceuticals: Advancing Therapies For Viral, Neuropathic And Neurodegenerative Diseases
Stock Information

Company Name: NeuroBo Pharmaceuticals Inc.
Stock Symbol: NRBO
Market: NASDAQ
Website: neurobopharma.com

Menu

NRBO NRBO Quote NRBO Short NRBO News NRBO Articles NRBO Message Board
Get NRBO Alerts

News, Short Squeeze, Breakout and More Instantly...